Emconcor review

Emconcor, a selective adrenergic receptor blocker belonging to a class of medications, works directly on the heart and blood circulation. It is mainly used to treat cardiovascular illnesses such as high blood pressure (high blood pressure), coronary heart disease, irregular heartbeats (irregular heartbeat), ischemic heart disease (restricted blood supply to the heart), and myocardial infarction (necrosis of the heart muscle leading to heart attack).

Emconcor works by blocking the heart's beta-adrenergic receptors, found in the body's sympathetic nervous system. This reduces the heart rate, preventing an abnormal rapid heartbeat, while relaxing the blood vessels so the heart does not need to pump too hard.

This medication is prescribed to patients with congestive heart failure to reduce the heart muscle's oxygen consumption. It decreases the heart's contraction force, lowering blood pressure and lessening the heart's need for oxygen. When the heart's need for oxygen exceeds the amount supplied, heart pain or angina occurs. This makes Emconcor ideal for the treating angina.

This medication can also be used in the treatment of dysautonomia (disorder of the autonomic nervous system), anxiety, and hyperthyroidism (an overactive thyroid gland).

Prior to taking Emconcor, patients should inform their doctor if they are allergic to this or any medication. The doctor should be advised if the patient is currently taking any prescription or over-the-counter medications, including vitamins, minerals or herbal supplements. For patients taking calcium channel blockers like diltiazem, verapamil, clonidine, or guanethidine, your doctor will need to alter the Emconcor dosage. Patients taking this medication should not be taking medications indicated for irregular heartbeat like disopyramide, other beta blockers like reserpine, or other contraindicated medications such as rifampin and digoxin. In cases where the doctor determines prescribing this medication in conjunction with any of the aforementioned medications, close monitoring during Emconcor therapy is necessary.

Emconcor is not recommended and is contraindicated for patients with asthma or other bronchial illnesses; a slow heart rate; a history of heart failure; any existing liver, kidney or heart disease; diabetes; allergies; circulation disorders, or hyperthyroidism.

The FDA classified Emconcor in pregnancy category C, which means it is not known whether the medication can harm an unborn child. Female patients need to inform their doctor if they are pregnant, plan to become pregnant, or if they do become pregnant during the course of treatment. Patients that are breastfeeding an infant will need to consult with their doctor prior to taking this medication since Emconcor can be secreted into breastmilk and may harm a nursing infant.

Patients need to disclose their existing Emconcor therapy prior to any type of surgery, including dental procedures. Emconcor treatment will have to be temporarily ceased, under medical supervision, before undergoing a surgical procedure.

Emconcor can cause drowsiness and reduce alertness, so patients are advised not to drive a vehicle or operate any kind of machinery while on this medication. Patients should avoid alcohol consumption while taking Emconcor since drinking alcoholic beverages may also exacerbate the effect of dizziness that Emconcor may cause.

Emconcor causes some side effects that are mild and easily tolerated by most patients. In rare instances, patients may develop headaches, nausea, abdominal cramping, diarrhea, erectile dysfunction, slow heart rate, unexplained weight gain, low blood pressure, numbness and tingling, sore throat, clamminess and swelling of the hands and feet, fainting, and wheezing or shortness of breath. If these symptoms persist, patients are advised to consult their doctor immediately.

Diabetics should inform their doctor if they are taking Emconcor, since the medication can alter the results of blood tests for diabetes, particularly those for hypoglycemia, or low blood sugar.

Distributed under the brand names Concor, Zebeta, Concore and Monocor, this medication is available by prescription in 5mg and 10mg pink, heart-shaped, film-coated pills. Emconcor should be taken orally according to the doctor's prescription, once daily with water, at the same time each day. The doctor may prescribe a low-salt diet to complement treatment.

Because Emconcor may form part of a comprehensive treatment program for high blood pressure, it cannot get rid of the disease altogether. Patients need to stick to a healthy diet, regular exercise and their prescribed medication to control high blood pressure.

Emconcor is a preventive maintenance medication that a patient may need to take for the rest of their lives, even in the absence of hypertensive symptoms. Suddenly stopping Emconcor therapy without medical advice may cause the patient's condition to worsen.

Emconcor has the following structural formula:

Chemical structure of emconcor

• Molecular formula of emconcor is C18H31NO4
• Chemical IUPAC Name is 1-[4-[2-(1-methylethoxy)ethoxymethyl]phenoxy]-3-(1-methylethylamino)propan-2-ol
• Molecular weight is 325.443 g/mol
Emconcor available : 5mg tablets, 10mg tablets

Generic name: Bisoprolol

Brand name(s): Cardicor, Concor, Condyline, Condylox, Detensiel, Emcor, Euradal, Isoten, Monocor, Soloc, Soprol, Zebeta, Ziac

  Your Emconcor review